ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/Radiation-Resistant Ovarian Cancer Patient Harboring a PD-L1-Genetic Rearrangement.

Stefania Bellone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.